🚀 VC round data is live in beta, check it out!
Scitop Bio-tech Valuation Multiples
Discover revenue and EBITDA valuation multiples for Scitop Bio-tech and similar public comparables like Jamieson Wellness, Mega Lifesciences, PharmaNutra, Procter & Gamble Health and more.
Scitop Bio-tech Overview
About Scitop Bio-tech
Beijing Scitop Bio-tech Co Ltd is engaged in production and sales of compound food additives, edible probiotic products and animal and plant micro-ecological preparations. The company engages in provision of biotechnology services, consulting, development, transfer; development and sale of stereotyped packaged food additives, compound food additives. Its products include Probio-M8 and Probio-M9.
Founded
2003
HQ
Employees
402
Website
Financials (FY)
EV
$955M
Scitop Bio-tech Financials
Scitop Bio-tech reported last fiscal year revenue of $44M and EBITDA of $20M.
In the same fiscal year, Scitop Bio-tech generated $26M in gross profit, $20M in EBITDA, and $14M in net income.
Revenue (LTM)
Scitop Bio-tech P&L
In the most recent fiscal year, Scitop Bio-tech reported revenue of $44M and EBITDA of $20M.
Scitop Bio-tech expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $44M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $26M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 58% | XXX | XXX | XXX |
| EBITDA | — | XXX | $20M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 45% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 34% | XXX | XXX | XXX |
| Net Profit | — | XXX | $14M | XXX | XXX | XXX |
| Net Margin | — | XXX | 31% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Scitop Bio-tech Stock Performance
Scitop Bio-tech has current market cap of $983M, and enterprise value of $955M.
Market Cap Evolution
Scitop Bio-tech's stock price is $3.73.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $955M | $983M | 0.0% | XXX | XXX | XXX | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialScitop Bio-tech Valuation Multiples
Scitop Bio-tech trades at 21.5x EV/Revenue multiple, and 48.1x EV/EBITDA.
EV / Revenue (LTM)
Scitop Bio-tech Financial Valuation Multiples
As of April 19, 2026, Scitop Bio-tech has market cap of $983M and EV of $955M.
Equity research analysts estimate Scitop Bio-tech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Scitop Bio-tech has a P/E ratio of 71.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $983M | XXX | $983M | XXX | XXX | XXX |
| EV (current) | $955M | XXX | $955M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 21.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 48.1x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 63.9x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 36.9x | XXX | XXX | XXX |
| P/E | — | XXX | 71.1x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (93.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Scitop Bio-tech Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Scitop Bio-tech Margins & Growth Rates
Scitop Bio-tech's revenue in the last fiscal year grew by 1%.
Scitop Bio-tech's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Scitop Bio-tech Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 45% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 10% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Scitop Bio-tech Public Comps
See public comps and valuation multiples for other Nutraceuticals & Cosmeceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Scitop Bio-tech | XXX | XXX | XXX | XXX | XXX | XXX |
| Jamieson Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
| Mega Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| PharmaNutra | XXX | XXX | XXX | XXX | XXX | XXX |
| Procter & Gamble Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Genomma Lab | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Scitop Bio-tech M&A Activity
Scitop Bio-tech acquired XXX companies to date.
Last acquisition by Scitop Bio-tech was on XXXXXXXX, XXXXX. Scitop Bio-tech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Scitop Bio-tech
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialScitop Bio-tech Investment Activity
Scitop Bio-tech invested in XXX companies to date.
Scitop Bio-tech made its latest investment on XXXXXXXX, XXXXX. Scitop Bio-tech invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Scitop Bio-tech
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Scitop Bio-tech
| When was Scitop Bio-tech founded? | Scitop Bio-tech was founded in 2003. |
| Where is Scitop Bio-tech headquartered? | Scitop Bio-tech is headquartered in China. |
| How many employees does Scitop Bio-tech have? | As of today, Scitop Bio-tech has over 402 employees. |
| Is Scitop Bio-tech publicly listed? | Yes, Scitop Bio-tech is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Scitop Bio-tech? | Scitop Bio-tech trades under 300858 ticker. |
| When did Scitop Bio-tech go public? | Scitop Bio-tech went public in 2020. |
| Who are competitors of Scitop Bio-tech? | Scitop Bio-tech main competitors are Jamieson Wellness, Mega Lifesciences, PharmaNutra, Procter & Gamble Health. |
| What is the current market cap of Scitop Bio-tech? | Scitop Bio-tech's current market cap is $983M. |
| What is the current revenue of Scitop Bio-tech? | Scitop Bio-tech's last fiscal year revenue is $44M. |
| What is the current EV/Revenue multiple of Scitop Bio-tech? | Current revenue multiple of Scitop Bio-tech is 21.5x. |
| Is Scitop Bio-tech profitable? | No, Scitop Bio-tech is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.